4-(4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzyl)morpholine
Intermediate
IntermediateConfidentiality：Public
- INN / Generic Name
- 4-(4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzyl)morpholine
- CAS No.
- 364794-79-6
- Current Status
- Official intermediate catalog (API: Tazemetostat Hydrobromide)
- MOQ
- On request
- Lead Time
- On request
- Price Range
- On request
Formulation & registration fields (API/FDF oriented — tap to expand)
- Dosage Form
- —
- Strength
- —
- Therapy Area
- Pharmaceutical Intermediates
- Indication
- API: Tazemetostat Hydrobromide
- GMP Certification
- —
- CEP
- No
- DMF Type
- —
- Stability Data
- —
- BE Required
- Not required / waivable
- Registration Pathway
- FSO supply (non-registered substance)
HS Code
2933.591100 customs bills on file
Registrable Markets
Global
Process / Sequence / Exact Price
- Process Summary
- Intermediate #4 of Route 2 (6 steps) for Cabamiquine. Route materials include: 6-fluoro-2-hydroxyquinoline-4-carboxylic acid, 2-chloro-6-fluoroquinoline-4-carbonyl chloride, 2-chloro-6-fluoro-N-(2-(pyrrolidin-1-yl)ethyl)quinoline-4-carboxamide, 1-bromo-4-(bromomethyl)benzene, 4-(4-bromobenzyl)morpholine. Source: Pharmacodia route data (in-house patent-cliff DB); full step sequence via SciFinder / Google Patents.Synthesis route auto-filled from in-house Pharmacodia route data — verify full steps on SciFinder / Google Patents.
- Exact Price